1. Short title This Act may be cited as the COVID–19 in Corrections Data Transparency Act . 2. Definitions In this Act: (1) COVID– 19 The term COVID–19 means Coronavirus Disease 2019. (2) COVID–19 diagnostic test The term COVID–19 diagnostic test means a test— (A) that is an in vitro diagnostic product (as defined in section 809.3 of title 21, Code of Federal Regulations, or any successor thereto) for the detection of SARS–CoV–2 or the diagnosis of the virus that causes COVID–19; and (B) the administration of which— (i) is approved, cleared, or authorized under section 510(k), 513, 515, or 564 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360(k) , 360c, 360e, 360bbb–3); (ii) the developer has requested, or intends to request, emergency use authorization under section 564 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bbb–3 ), unless and until the emergency use authorization request under such section 564 has been denied or the developer of such test does not submit a request under such section within a reasonable timeframe; (iii) is developed in and authorized by a State that has notified the Secretary of Health and Human Services of its intention to review tests intended to diagnose COVID–19; or (iv) is another test that the Secretary determines appropriate in guidance. (3) COVID–19 emergency data collection period The term COVID–19 emergency data collection period means the period beginning on the date of enactment of this Act and ending on the date that is 1 year after date on which the public health emergency declaration under section 319 of the Public Health Service Act ( 42 U.S.C. 247d ), with respect to COVID–19, terminates. (4) State or local correctional facility The term State or local correctional facility — (A) means a correctional facility within the jurisdiction of a State or unit of local government; and (B) includes— (i) a municipal, regional, or county jail; (ii) a State prison; (iii) a State-run boot camp prison; (iv) a boot camp prison that is contracted out by the State